Barclays PLC Becton Dickinson & CO Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Barclays PLC holds 765,309 shares of BDX stock, worth $132 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
765,309
Previous 512,401
49.36%
Holding current value
$132 Million
Previous $116 Million
50.8%
% of portfolio
0.05%
Previous 0.03%
Shares
31 transactions
Others Institutions Holding BDX
# of Institutions
1,806Shares Held
257MCall Options Held
3.24MPut Options Held
841K-
Vanguard Group Inc Valley Forge, PA28MShares$4.83 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$3.84 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$2.41 Billion0.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$2.17 Billion1.91% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$1.95 Billion0.32% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $49.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...